within Pharmacolibrary.Drugs.ATC.R;

model R06AB54
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 24 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,
    adminCount     = 1,
    Vd             = 0.15,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Chlorphenamine, often combined with other agents in cold and allergy medicines, is a first-generation antihistamine used for symptomatic relief of allergic conditions such as rhinitis, urticaria, and hay fever. It is an older medication, still in use today as an over-the-counter remedy for allergy and cold symptoms. Combinations may include analgesics, decongestants, and sometimes antitussives.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetics in healthy adult subjects (mixed-sex) for oral combination formulations. No direct literature source specifically for the combination product, parameters estimated based on single-agent chlorphenamine data.</p><h4>References</h4><ol><li><p>Mann, KV, et al., &amp; Tietze, KJ (1989). Nonsedating histamine H1-receptor antagonists. <i>Clinical pharmacy</i> 8(5) 331–344. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2568212/&quot;>https://pubmed.ncbi.nlm.nih.gov/2568212</a></p></li><li><p>Bernstein, JA (2007). Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. <i>Current medical research and opinion</i> 23(10) 2441–2452. DOI:<a href=&quot;https://doi.org/10.1185/030079907X226302&quot;>10.1185/030079907X226302</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17723160/&quot;>https://pubmed.ncbi.nlm.nih.gov/17723160</a></p></li><li><p>Howland, WC, et al., &amp; Field, EA (1996). The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects. <i>Clinical therapeutics</i> 18(6) 1106–1117. DOI:<a href=&quot;https://doi.org/10.1016/s0149-2918(96)80065-8&quot;>10.1016/s0149-2918(96)80065-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9001827/&quot;>https://pubmed.ncbi.nlm.nih.gov/9001827</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R06AB54;
